Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 2 for SAPTALIS PHARMS.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
SAPTALIS PHARMS: 0 warning letters, 0 recalls, 2 approval records, 0 Form 483s.
Side by side
Philips North America — Warning letters0
SAPTALIS PHARMS — Warning letters0
Philips North America — Recalls355
SAPTALIS PHARMS — Recalls0
Philips North America — Approval records0
SAPTALIS PHARMS — Approval records2
Philips North America — Form 483s0
SAPTALIS PHARMS — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Philips North America vs SAPTALIS PHARMS: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/philips-north-america-vs-saptalis-pharms
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗